home · filing · 0001493152-24-046863
8-K
filed November 19, 2024, 6:59 PM ET
ticker SINT
CIK 0001269026
leadership
confidence high
sentiment positive
materiality 0.35
SINTX appoints Gregg Honigblum as Chief Strategy Officer; 6-month term, $137,500 base salary
Sintx Technologies, Inc.
Gregg Honigblum appointed CSO effective Nov 15, 2024; previously Managing Director at FNEX Capital.
Employment agreement: 6-month term, $137,500 base salary, eligible for bonuses and equity awards.
Severance if terminated without cause: base salary for longer of 3 months or remainder of term.
Honigblum has over 35 years experience in healthcare and investment banking; raised over $500M.
Instrumental in early-stage capital for Myriad Genetics and early investor in Acacia Biosciences.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-11-15
Filed November 19, 2024, 6:59 PM ET
Gregg Honigblum has been appointed to serve as SINTX Technologies, Inc.’s (the “Company”) Chief Strategy Officer effective November 15, 2024.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Gregg Honigblum was appointed as Chief Strategy Officer at Sintx Technologies, Inc..
Action appointed
Role Chief Strategy Officer
Exact text from the filing
Gregg Honigblum has been appointed to serve as SINTX Technologies, Inc.’s (the “Company”) Chief Strategy Officer effective November 15, 2024.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-24-046863
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.